AU5034099A - Method for identifying a presenilinase inhibitor - Google Patents
Method for identifying a presenilinase inhibitorInfo
- Publication number
- AU5034099A AU5034099A AU50340/99A AU5034099A AU5034099A AU 5034099 A AU5034099 A AU 5034099A AU 50340/99 A AU50340/99 A AU 50340/99A AU 5034099 A AU5034099 A AU 5034099A AU 5034099 A AU5034099 A AU 5034099A
- Authority
- AU
- Australia
- Prior art keywords
- presenilinase
- inhibitor
- identifying
- presenilinase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98112688 | 1998-07-09 | ||
| EP98112688 | 1998-07-09 | ||
| PCT/EP1999/004805 WO2000003248A1 (en) | 1998-07-09 | 1999-07-08 | Method for identifying a presenilinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5034099A true AU5034099A (en) | 2000-02-01 |
Family
ID=8232244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50340/99A Abandoned AU5034099A (en) | 1998-07-09 | 1999-07-08 | Method for identifying a presenilinase inhibitor |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1095279A1 (en) |
| JP (1) | JP2002520031A (en) |
| AR (1) | AR020107A1 (en) |
| AU (1) | AU5034099A (en) |
| CA (1) | CA2332344A1 (en) |
| UY (1) | UY25604A1 (en) |
| WO (1) | WO2000003248A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10000161A1 (en) * | 2000-01-06 | 2001-07-19 | Boehringer Ingelheim Pharma | Method of identifying a protease inhibitor |
| AU2001249717B2 (en) * | 2000-04-03 | 2006-03-30 | Bristol-Myers Squibb Company | Fluorescence assay for gamma-secretase activity and inhibitors |
| EP3796980A4 (en) * | 2018-05-22 | 2022-03-23 | The Brigham & Women's Hospital, Inc. | GENE THERAPY FOR ALZHEIMER'S DISEASE |
| EP3976637A4 (en) | 2019-05-24 | 2023-07-12 | The Brigham and Women's Hospital, Inc. | GENE THERAPY FOR ALZHEIMER'S DISEASE |
| MX2022006499A (en) | 2019-11-29 | 2022-08-15 | Paros Bio Inc | Gene therapy for neurodegenerative disorders. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997027296A1 (en) * | 1996-01-26 | 1997-07-31 | Hsc Research And Development Limited Partnership | Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| GB9608657D0 (en) * | 1996-04-26 | 1996-07-03 | Smithkline Beecham Plc | Novel treatment |
| CA2288227A1 (en) * | 1997-04-24 | 1998-10-29 | The General Hospital Corporation | A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 |
-
1999
- 1999-07-07 AR ARP990103295A patent/AR020107A1/en unknown
- 1999-07-08 EP EP99934634A patent/EP1095279A1/en not_active Withdrawn
- 1999-07-08 AU AU50340/99A patent/AU5034099A/en not_active Abandoned
- 1999-07-08 CA CA002332344A patent/CA2332344A1/en not_active Abandoned
- 1999-07-08 WO PCT/EP1999/004805 patent/WO2000003248A1/en not_active Ceased
- 1999-07-08 JP JP2000559432A patent/JP2002520031A/en active Pending
- 1999-07-09 UY UY25604A patent/UY25604A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000003248A1 (en) | 2000-01-20 |
| EP1095279A1 (en) | 2001-05-02 |
| AR020107A1 (en) | 2002-04-10 |
| CA2332344A1 (en) | 2000-01-20 |
| JP2002520031A (en) | 2002-07-09 |
| UY25604A1 (en) | 2000-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001290616A1 (en) | A method for identifying polymorphisms | |
| AU3186199A (en) | A method for optimizing risk management | |
| AU2001294745A1 (en) | System and method for identifying a product | |
| AU2829399A (en) | Method for introducing solder into a system | |
| AU2048700A (en) | A method for increasing electronic business | |
| AU2340997A (en) | A method for inhibiting clot formation | |
| EP0897800B8 (en) | A recording method | |
| AU6627698A (en) | Method for sterilising a sample | |
| AU2452899A (en) | Method for etching | |
| AU1337099A (en) | Method for identifying micro-organisms | |
| AU2620899A (en) | Method for introducing solder into a system | |
| AU6645398A (en) | Method for protecting bytecode | |
| AU6925298A (en) | Method for machining a crankshaft | |
| AU5034099A (en) | Method for identifying a presenilinase inhibitor | |
| AU3981799A (en) | Method for identifying genes | |
| AU1034700A (en) | A method for identifying bad frames | |
| AU2001283792A1 (en) | Method for automatically identifying a directed structure | |
| AU9013498A (en) | Method for a bending procedure | |
| AU4784799A (en) | Method for forming a nickel-titan plating | |
| AU2649699A (en) | A method for manufacturing a cable | |
| AU1723599A (en) | A method for identifying new anti-picornaviral compounds | |
| AU6350099A (en) | Contaminant removal method | |
| AU5868798A (en) | Method for reducing a carbonyl-containing compound | |
| AU3789100A (en) | Method for utilizing waste | |
| AU2002223099A1 (en) | A method for identifying enzyme inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |